Sepsis Therapeutics- Pipeline Analysis 2018 | NovImmune, Asahi Kasei Pharma America

Sepsis refers to inflammation throughout the body, as a result of immune response to fight an infection. Severe cases of sepsis can lead to septic shock. According to the data published by the Centers for Disease Control and Prevention, more than one million people suffer from sepsis each year.

Download the sample report @ https://www.pharmaproff.com/request-sample/1071

Pneumonia, abdominal, kidney, and bloodstream infections are more likely to cause sepsis. Exposure to invasive devices, young children, seniors, intensive care unit (ICU) patients and people with weaker immune systems are at higher risk of developing sepsis.

Get the detailed analysis @ https://www.pharmaproff.com/report/sepsis-therapeutics-pipeline-analysis

Sepsis can be treated by antibiotics, vasoactive medications, corticosteroids, and painkillers. Asahi Kasei Pharma, a subsidiary Asahi Kasei Pharma America Corp. is in the process of developing ART-123, for the treatment of severe sepsis with coagulopathy. Novimmune SA and INOTREM S.A. are also involved in sepsis pipeline.

Make enquiry before purchase @ https://www.pharmaproff.com/enquiry/1071

• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com

This release was published on openPR.